Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cell Death and Differentiation

• Publication date

  2004-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.cdd.4401389PMID 15002036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia

  2003cited by this paper
• Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.

  2002cited by this paper
• Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.

  2001cited by this paper
• Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.

  2001cited by this paper
• Evidence for the association of ultraviolet-C and H(2)O(2)-induced apoptosis with acid sphingomyelinase activation.

  2001cited by this paper
• Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic.

  2001cited by this paper
• Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis.

  2000cited by this paper
• TNF-α AND IL-1α INDUCE APOPTOSIS IN SUBCONFLUENT RAT MESANGIAL CELLS. EVIDENCE FOR THE INVOLVEMENT OF HYDROGEN PEROXIDE AND LIPID PEROXIDATION AS SECOND MESSENGERS

  2000cited by this paper
• Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen‐sensitive prostate cancer cells introduced with green fluorescent protein

  2000cited by this paper
• Effect of calcium on reactive oxygen species in isolated rat cardiomyocytes during hypoxia and reoxygenation.

  2000cited by this paper
• Superoxide dismutase as a target for the selective killing of cancer cells

  2000cited by this paper
• TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengers.

  2000cited by this paper
• CROP/Luc7A, a novel serine/arginine‐rich nuclear protein, isolated from cisplatin‐resistant cell line1

  2000cited by this paper
• Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

  1999cited by this paper
• Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.

  1999cited by this paper
• Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway

  1999cited by this paper
• L-S,R-buthionine sulfoximine: historical development and clinical issues.

  1998cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

  1997cited by this paper
• Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.

  1997cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

  1997cited by this paper
• Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.

  1997cited by this paper
• Multifactorial Involvement of Multidrug Resistance Protein, DNA Topoisomerase II and Glutathione/Glutathione‐S‐Transferase in NonP‐ Glycoprotein‐Mediated Multidrug Resistance in Human Bladder Cancer Cells

  1997cited by this paper
• Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells.

  1997cited by this paper
• A new nitric oxide scavenger, imidazolineoxyl N-oxide derivative, and its effects in pathophysiology and microbiology.

  1995cited by this paper
• Role of free radicals and catalytic metal ions in human disease: an overview.

  1990cited by this paper
• Expression: a Novel Approach for Cancer Gene Therapy Prostate-specific Amplification of Expanded Polyglutamine Updated Version Citing Articles E-mail Alerts Prostate-specific Amplification of Expanded Polyglutamine Expression: a Novel Approach for Cancer Gene Therapy1

  year unknowncited by this paper

• New insights into reductive stress responses and its clinical relation in cancer.

  2025cites this paper
• Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

  2024influential citation
• Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model

  2024cites this paper
• Near-infrared-II photocharging nanozyme for enhanced tumor immunotherapy.

  2024cites this paper
• Involvement of Mitochondrial Damage and Oxidative Stress in Apoptosis Induced by Betulin Plus Arsenic Trioxide in Neuroblastoma Cells

  2023cites this paper
• Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies

  2023cites this paper
• Heavy Pnictogens Based Organometallic Luminescent Materials

  2023cites this paper
• Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.

  2022cites this paper
• Liposomal formulation of new arsenic schiff base complex as drug delivery agent in the treatment of acute promyelocytic leukemia and quantum chemical and docking calculations

  2022cites this paper
• Construction of multifunctional mesoporous silicon nano-drug delivery system and study of dual sensitization of chemo-photodynamic therapy in vitro and in vivo.

  2022cites this paper
• Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal of pancreatic stellate cell desmoplasia by targeting the AP4/galectin-1 pathway.

  2022cites this paper
• Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy.

  2022cites this paper
• Enhanced antitumor effect of l-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models

  2022cites this paper
• Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox

  2022cites this paper
• Recent Advances in the Development of Synthetic Pro-oxidants: Implications for ROS based Cancer Therapeutics

  2022cites this paper
• F-box protein FBXO41 plays vital role in arsenic trioxide-mediated autophagic death of cancer cells.

  2022cites this paper
• A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance

  2022cites this paper
• Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.

  2021cites this paper
• Copper arsenite-complexed Fenton-like nanoparticles as oxidative stress-amplifying anticancer agents.

  2021cites this paper
• Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy

  2021cites this paper
• Thioredoxin 1 is required for stress granule assembly upon arsenite-induced oxidative stress.

  2021cites this paper
• Engineering nanomedicine for glutathione depletion-augmented cancer therapy.

  2021cites this paper
• Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance

  2021cites this paper
• ROS and Oxidative Stress in Cancer: Recent Advances

  2020cites this paper
• Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin

  2020cites this paper
• Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

  2020cites this paper
• Tumor targeted self-synergistic nanoplatforms for arsenic-sensitized photodynamic therapy.

  2020cites this paper
• Ultra-small Bi2S3 nanodot-doped reversible Fe(ii/iii)-based hollow mesoporous Prussian blue nanocubes for amplified tumor oxidative stress-augmented photo-/radiotherapy.

  2020cites this paper
• Specific "Unlocking" Nanozyme-based Butterfly Effect for Breaking the Evolutionary Fitness of Chaotic Tumor.

  2020cites this paper
• Progresses and emerging trends of arsenic research in the past 120 years

  2020cites this paper
• Small molecules regulating reactive oxygen species homeostasis for cancer therapy

  2020cites this paper
• Highly stable and biocompatible hyaluronic acid-rehabilitated nanoscale MOF-Fe2+ induced ferroptosis in breast cancer cells.

  2020cites this paper
• Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging

  2020cites this paper
• The Role of Oxidative Stress in Cancer

  2020cites this paper
• Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent

  2019cites this paper
• Exploiting the Mitochondrial Fox 03A/SIRT3 Complex in Cancer Therapy

  2019cites this paper
• Amplification of Oxidative Stress in MCF-7 Cells by a Novel pH-Responsive Amphiphilic Micellar System Enhances Anticancer Therapy.

  2019cites this paper
• Glutathione Metabolism in Yeasts and Construction of the Advanced Producers of This Tripeptide

  2019cites this paper
• Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance.

  2019cites this paper
• Modulating intracellular oxidative stress via engineered nanotherapeutics.

  2019cites this paper
• Regulating intracellular ROS signal by a dual pH/reducing-responsive nanogels system promotes tumor cell apoptosis

  2019cites this paper
• Fabrication of H2O2-driven nanoreactors for innovative cancer treatments.

  2019cites this paper
• Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit

  2019cites this paper
• Arsenic Disulfide Combined with L-Buthionine-(S, R)-Sulfoximine Induces Synergistic Antitumor Effects in Two-Dimensional and Three-Dimensional Models of MCF-7 Breast Carcinoma Cells.

  2019cites this paper
• Nicotinamide Nucleotide Transhydrogenase as a novel treatment 1 target in adrenocortical carcinoma 2 3

  2019cites this paper
• Novel Combination of Arsenic Trioxide (As2O3) Plus Resveratrol in Inducing Programmed Cell Death of Human Neuroblastoma SK-N-SH Cells

  2018cites this paper
• Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.

  2018cites this paper
• Glutathione system in animal model of solid tumors: From regulation to therapeutic target.

  2018cites this paper
• Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side

  2018influential citation
• Redox- and pH-Responsive Nanoparticles Release Piperlongumine in a Stimuli-Sensitive Manner to Inhibit Pulmonary Metastasis of Colorectal Carcinoma Cells.

  2018cites this paper
• Extractive recovery and valorisation of arsenic from contaminated soil through phytoremediation using Pteris cretica.

  2018cites this paper
• Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma

  2018cites this paper
• Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane

  2018cites this paper
• Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency

  2018cites this paper
• Mitochondrien als potenzielle Zielstruktur in der Krebstherapie

  2018cites this paper
• Investigation of the intracellular oxidative stress amplification, safety and anti-tumor effect of a kind of novel redox-responsive micelle.

  2018cites this paper
• Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity

  2018cites this paper
• Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers

  2017influential citation
• Modulation of cell death in human colorectal and breast cancer cells through a manganese chelate by involving GSH with intracellular p53 status

  2017cites this paper
• ROS-modulated therapeutic approaches in cancer treatment

  2017cites this paper
• Chrysin and silibinin sensitize human glioblastoma cells for arsenic trioxide.

  2017cites this paper
• Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance

  2017cites this paper
• Developing new diagnostic and therapeutic approaches in adrenocortical carcinoma

  2017cites this paper
• Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein

  2017cites this paper
• Reactive Oxygen Species Synergize To Potently and Selectively Induce Cancer Cell Death.

  2017cites this paper
• Dual Stimuli-Activatable Oxidative Stress Amplifying Agent as a Hybrid Anticancer Prodrug.

  2017cites this paper
• Investigating metal aberrations in cellular senescence

  2017cites this paper
• An in vitro investigation of the antitumour efficacy of novel hybrids containing artemisinin, porphyrin, or naphthalimide derivatives /

  2017cites this paper
• Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation

  2016cites this paper
• Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma

  2016cites this paper
• The Hallmarks of Cancer from a Redox Perspective

  2016cites this paper
• Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells

  2016cites this paper
• Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.

  2016cites this paper
• Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution

  2016cites this paper
• ROS-Inducing Agents for Cancer Chemotherapy

  2016cites this paper
• Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.

  2016cites this paper
• Targeting ROS for Cancer Therapy

  2016cites this paper
• Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules.

  2015cites this paper
• Bioremediation of Toxic Metals Using Algae

  2015cites this paper
• Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(i) complexes in A549 lung cancer cells

  2015cites this paper
• Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.

  2015cites this paper
• Antioxidant supplementation on cancer risk and during cancer therapy: an update.

  2015cites this paper
• Redox modulation of oxidatively induced DNA damage by ascorbate enhances melanoma cancer cell DNA damage formation & cell killing

  2015cites this paper
• Ozone Therapy: A Critical Physiological and Diverse Clinical Evaluation with Regard to Immune Modulation, Anti-Infectious Properties, Anti-Cancer Potential, and Impact on Anti-Oxidant Enzymes

  2015cites this paper
• Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death

  2015cites this paper
• Cancer therapy: Targeting mitochondria and other sub-cellular organelles.

  2014cites this paper
• Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro

  2014cites this paper
• Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: effects of genistein, quercetin and buthionine-sulfoximine.

  2014influential citation
• Targeting antioxidants for cancer therapy.

  2014cites this paper
• The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity

  2014cites this paper
• BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine

  2014cites this paper
• Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.

  2014cites this paper
• Reactive oxygen species in cancer biology and anticancer therapy.

  2013cites this paper
• Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.

  2013cites this paper
• Increased glutathione and mitogen‐activated protein kinase phosphorylation are involved in the induction of doxorubicin resistance in hepatocellular carcinoma cells

  2013cites this paper
• Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide.

  2013cites this paper
• Cytosolic Ca2+ shifts as early markers of cytotoxicity

  2013cites this paper
• Indomethacin-Enhanced Anticancer Effect of Arsenic Trioxide in A549 Cell Line: Involvement of Apoptosis and Phospho-ERK and p38 MAPK Pathways

  2013cites this paper
• Role of Glutathione in Cancer Progression and Chemoresistance

  2013cites this paper
• Double-edged effects of arsenic compounds: anticancer and carcinogenic effects.

  2013cites this paper